Cell lines of myeloid lineage are selectively dependent on CoREST1 for survival consistent with existing preclinical and clinical data on LSD1 inhibitors in AML, whereas LSD1 dependency does not appear to be selective across cancer lineages. This evidence concerns the gene KDM1A and acute myeloid leukemia.